J. Zucman‐Rossi
Hepatology · 2001–2017
A researcher in the Science corpus: 13 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Hepatology — 115 citations into it
Whom J. Zucman‐Rossi trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts J. Zucman‐Rossi overall
Papers from J. Zucman‐Rossi's perspective
Ordered by how strongly the researchers J. Zucman‐Rossi trusts endorse each paper. Same corpus, a different order for every researcher.
- Molecular pathogenesis of human hepatocellular carcinoma (Nature Genetics)
- Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. (New England Journal of Medicine)
- The hallmarks of cancer (RNA Biology)
- Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. (New England Journal of Medicine)
- Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA (Science)
- Hepatocellular carcinoma: recent trends in the United States. (Gastroenterology)
- Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. (New England Journal of Medicine)
- Aberrant promoter methylation of multiple genes in non-small cell lung cancers. (Cancer Research)
- Transcription-coupled DNA repair: two decades of progress and surprises (Nature reviews. Molecular cell biology)
- The origin and evolution of mutations in Acute Myeloid Leukemia (Cell)
Their papers
- Signatures of mutational processes in human cancer (2013) — 9,146 citations
- International network of cancer genome projects (2010) — 2,229 citations
- Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma (2012) — 1,390 citations
- Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets (2007) — 1,163 citations
- Toward understanding and exploiting tumor heterogeneity (2015) — 708 citations
- Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. (2001) — 598 citations
- Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification. (2017) — 656 citations
- Hepatocellular carcinoma (2016) — 1,645 citations
- Mechanisms of HBV-induced hepatocellular carcinoma. (2016) — 967 citations
- Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets (2015) — 1,627 citations
- Genetic Landscape and Biomarkers of Hepatocellular Carcinoma. (2015) — 1,184 citations
- MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations (2008) — 711 citations
- Genotype–phenotype correlation in hepatocellular adenoma: New classification and relationship with HCC (2006) — 766 citations